Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV
Wilfried A.M. Bakkera,∗, Yvonne E. Thomassen, Aart G. van’t Oever, Janny Westdijk, Monique G.C.T. van Oijen, Lars C. Sundermann, Peter van’t Veld, Eelco Sleemand, Fred W. van Nimwegen, Ahd Hamidi, Gideon F.A. Kersten, Nico van den Heuvel, Jan T. Hendriks, Leo A. van der Pol
Technology transfer of Sabin-IPV to new developing country markets
Kreeftenberg, Hans ; Van der velden, Tiny ; Kersten, Gideon; Van der heuvel, Nico; De bruijn, Marloes; Biologicals 34(2): 155-158(2006)
Antigenic and immunogenic properties of Inactivated polio
Kersten, Gideon; Hazendonk, Ton; Beuvery, Coen; Vaccine 17: 2059-2066(1999)